España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Galapagos
GLPG
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$27.22
-0.01
-0.04%
At Close: -
$27.06
-0.16
-0.59%
After Hours: 8:33 AM EDT
15 minutes delayed
Get Report
Comment
Q2 2024 Earnings in 9 days from now on Thu Aug 1st, after the market close
Galapagos (GLPG) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Galapagos (NASDAQ:GLPG) Stock
Galapagos Stock (NASDAQ: GLPG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 14, 2024
Galapagos To Present Data On CD19 CAR-T Candi...
Benzinga Newsdesk
Thursday, May 30, 2024
Galapagos And Adaptimmune Enter Clinical Coll...
Benzinga Newsdesk
Wednesday, May 15, 2024
Galapagos And Blood Centers Of America Collab...
Benzinga Newsdesk
Thursday, May 02, 2024
Galapagos Q1 EPS €1.40 Vs €0.40 YoY; Revenue ...
Benzinga Newsdesk
Monday, April 22, 2024
Morgan Stanley Maintains Equal-Weight on Gala...
Benzinga Newsdesk
Thursday, April 04, 2024
Galapagos Plans Clinical And Translational Da...
Benzinga Newsdesk
Monday, April 01, 2024
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst
Vandana Singh
B of A Securities Downgrades Galapagos to Und...
Benzinga Newsdesk
Thursday, March 28, 2024
B of A Securities Downgrades Galapagos to Und...
Benzinga Newsdesk
Thursday, March 07, 2024
Morgan Stanley Assumes Galapagos at Equal-Wei...
Benzinga Newsdesk
Friday, February 23, 2024
Galapagos shares are trading lower following ...
Benzinga Newsdesk
Thursday, February 22, 2024
Galapagos Expects FY24 Further Reduction In C...
Benzinga Newsdesk
Galapgos FY23 EPS €3.21 Up From €(3.32) YoY R...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Friday, February 16, 2024
Galapagos To Present New Preliminary Translat...
Benzinga Newsdesk
Thursday, January 04, 2024
Galapagos Enters Strategic Collaboration Deal...
Benzinga Newsdesk
Wednesday, January 03, 2024
European Drugmaker Galapagos Collaborates With Biotech BridGene Biosciences To Develop Cancer Treatments
Vandana Singh
BridGene Says "Galapagos Will Pay Up To $27M ...
Benzinga Newsdesk
BridGene Biosciences Announces Strategic Coll...
Benzinga Newsdesk
Tuesday, January 02, 2024
B of A Securities Maintains Neutral on Galapa...
Benzinga Newsdesk
Galapagos Transforms Into Biotech Innovator, ...
Benzinga Newsdesk
Tuesday, December 19, 2023
Galapagos NV Announced That The First Patient...
Benzinga Newsdesk
Saturday, December 09, 2023
Galapagos To Present New Data At Ash 2023 From Ongoing CD19 Car-t Studies With GLPG5201 And GLPG5101
Charles Gross
Thursday, November 02, 2023
Galapagos Reiterates 2023 Net Jyseleca Sales ...
Benzinga Newsdesk
Galapagos 9-Month Total Net Revenues Up 9% To...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Monday, October 30, 2023
Galapagos Concludes Strategic Evaluation And ...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 28, 2023
Galapagos Says First patient Randomized In GA...
Benzinga Newsdesk
Galapagos Announces Start Of Phase 2 Study Wi...
Benzinga Newsdesk
Monday, August 07, 2023
Morgan Stanley Maintains Equal-Weight on Gala...
Benzinga Newsdesk
Thursday, August 03, 2023
Galapagos 1H Revenue €328.8M Vs €274M YoY
Happy Mohamed
Tuesday, August 01, 2023
Morgan Stanley Reiterates Equal-Weight on Gal...
Benzinga Newsdesk
Monday, July 31, 2023
Morgan Stanley Reiterates Equal-Weight on Gal...
Benzinga Newsdesk
Monday, July 24, 2023
Morgan Stanley Reiterates Equal-Weight on Gal...
Benzinga Newsdesk
Monday, July 17, 2023
8 Analysts Have This to Say About Galapagos
Benzinga Insights
Morgan Stanley Reiterates Equal-Weight on Gal...
Benzinga Newsdesk
Monday, June 26, 2023
Morgan Stanley Reiterates Equal-Weight on Gal...
Benzinga Newsdesk
Tuesday, June 20, 2023
Morgan Stanley Reiterates Equal-Weight on Gal...
Benzinga Newsdesk
Thursday, June 15, 2023
Galapagos Appoints Thad Huston As CFO And COO...
Benzinga Newsdesk
Monday, June 12, 2023
Where Galapagos Stands With Analysts
Benzinga Insights
Morgan Stanley Reiterates Equal-Weight on Gal...
Benzinga Newsdesk
Monday, June 05, 2023
Galapagos To Showcase CAR-T Point-Of-Care Man...
Benzinga Newsdesk
Wednesday, May 31, 2023
JP Morgan Maintains Neutral Rating for Galapagos: Here's What You Need To Know
Benzinga Insights
JP Morgan Maintains Neutral on Galapagos, Low...
Benzinga Newsdesk
Tuesday, May 23, 2023
Galapagos Announces Start Of Phase 2 Study Wi...
Benzinga Newsdesk
Tuesday, May 09, 2023
Morgan Stanley Maintains Equal-Weight on Gala...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch